| Company Name: | Electro Optical Sciences, Incorporated | | Ticker Symbol: | MELA | | | WWW Address: | www.eo-sciences.com | | CEO: | Dr. Joseph V. Gulfo, M.D. | | No. of Employees: | 37 | | Common Issue Type: | CS | | Business Description: | A medical device company, which is focused on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma.
|
| | | Industry Information: | HEALTH SERVICES - Medical Instruments & Supplies [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 9.98 |  0.24 | 9.02 | 13.0 | 9.95 | 10.27 | 9.81 | 580133 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 200.6 | 20.1 | 1.38 | -1.08 | 0.00 | 0.0 | 0.0 | 11.73 - 2.46 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 9.98 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 200.5 | mil |
| Latest Shares Outstanding | 20.1 | mil |
| Earnings pS (EPS) | -1.08 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 0 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 18.9 | mil |
| Float as % of Shares Outstanding | 94.3 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 0.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 0.0 | % |
| EBITDA Margin | 0.0 | % |
| Pre-Tax Profit Margin | 0.0 | % |
| Assets Turnover | 0.0 | % |
| Return on Assets (ROA) | -65.3 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -69.3 | % |
| Current Ratio | 16.5 | |
| Leverage Ratio (Assets/Equity) | 1.1 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 1.18 | $ |
| Cash pS | 1.23 | $ |
| Book-Value pS | 1.22 | $ |
| Tangible Book-Value pS | 1.22 | $ |
| Cash Flow pS | -0.79 | $ |
| Free Cash Flow pS | -0.83 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 8.15 | |
| Price/Tangible Book Ratio | 8.18 | |
| Price/Cash Flow | -12.6 | |
| Price/Free Cash Flow | -12.0 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 2.5 | 101 | 5,778 | 5,527 |
| 4 Weeks | 10.67 | 7.85 | 10.06 | -0.8 | 93 | 7,044 | 112,696 |
| 13 Weeks | 11.73 | 7.85 | 10.15 | -1.7 | 91 | 5,075 | 304,489 |
| 26 Weeks | 11.73 | 6.18 | 8.19 | 21.9 | 101 | 4,173 | 517,474 |
| 52 Weeks | 11.73 | 2.46 | 3.45 | 189.3 | 234 | 3,025 | 750,212 |
| YTD | 11.73 | 3.00 | - | 197.9 | 243 | 3,261 | 737,041 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 9.39 | 8.92 | 9.51 | 8.53 | 7.56 | 1.38 | 1.53 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 0.00 | 0.0 | 0.00 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.00 | NA | 24.93 |
| R&D | 0.00 | NA | 21.96 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 0.0 | 0.0 | 0.0 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.15 | -0.01 | -0.24 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 86.08 |
| Current Ratio | 10.4 |
| Quick Ratio (Acid Test) | 10.1 |
| Liquidity Ratio (Cash) | 10.11 |
| Receivables Turnover | 0.0 |
| Average Collection Period | 0 |
| Working Capital/Equity | 94.8 |
| Working Capital pS | 0.81 |
| Cash-Flow pS | -0.93 |
| Free Cash-Flow pS | -0.94 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 74.72 |
| Financial Leverage Ratio (Assets/Equity) | 1.1 |
| Debt Ratio | 9.2 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 0.0 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.85 |
| Tobin's Q Ratio | 12.06 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -10.91 |
| Enterprise Value (EV)/Free Cash Flow | -11.20 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 8.18 |
| Price/Book Ratio - LTM | 8.15 |
| Price/Cash Flow Ratio | -12.6 |
| Price/Free Cash Flow Ratio - LTM | -12.0 |
| Price/Sales Ratio | 0.00 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.09 |
| Tangible Book Value pS - LTM | 1.22 |
| Book Value pS - LTM | 1.22 |
| Capital Invested pS | 0.75 |
| Cash pS - LTM | 1.23 |
| Cash Flow pS - LTM | -0.79 |
| Free Cash Flow pS - LTM | -0.83 |
| Earnings pS (EPS) | -1.08 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 0.00 |
| Free Cash Flow Margin 5YEAR AVG | 0.00 |
| Net Profit Margin | 0.0 |
| Net Profit Margin - 5YEAR AVRG. | 0.0 |
| Equity Productivity | 0.00 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 0.00 |
| Return on Capital Invested (ROCI) | -116.7 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -70.2 |
| Assets Productivity | 0.00 |
| Return on Assets (ROA) | -105.9 |
| Return on Assets (ROA) - 5YEAR AVRG. | -57.7 |
| Gross Profit Margin | 0.0 |
| Gross Profit Margin - 5YEAR AVRG. | 0.0 |
| EBITDA Margin - LTM | 0.0 |
| EBIT Margin - LTM | 0.0 |
| Pre-Tax Profit Margin | 0.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 0.0 |
| Effective Tax Rate | 0.0 |
| Effective Tax Rate - 5YEAR AVRG. | 0.0 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 0 |
| Revenue per Employee | 0 |
| Net Income per Employee | -475,811 |
| Average Collection Period | 0 |
| Receivables Turnover | 0.0 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 0.00 |
| Assets/Revenue | 0.00 |
| Net Working Capital Turnover | 0.00 |
| Fixed Assets Turnover | 0.00 |
| Total Assets Turnover | 0.0 |
| Revenue per $ Cash | 0.00 |
| Revenue per $ Plant | 0.00 |
| Revenue per $ Common Equity | 0.00 |
| Revenue per $ Capital Invested | 0.00 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 0.0 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |